#PrEP

An epidemic of sexually transmitted hepatitis C among men who have sex with men has emerged.

The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.

HCV incidence in a Canadian study was lower than rates seen in some European countries.

The drug can quickly reverse opioid-driven overdoses.

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

For over 30 years, the California-based group fought for treatments, research, education and quality health care.

Nevertheless, researchers advise careful kidney monitoring when pairing the medications.

A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Another initiative of the Elton John AIDS Foundation will focus on HIV and hep C in Eastern Europe and Central Asia.

The rebranding reflects expanded services, including a medical clinic and a focus on STIs and hepatitis.

The World Health Organization (WHO) has added a new hepatitis C treatment to its updated 2017 Essential Medicines List.

Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.

The update includes a new combination therapy that can treat all six genotypes of HCV, a new HIV medication and PrEP.